{"id":"NCT02229851","sponsor":"Novo Nordisk A/S","briefTitle":"Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.","officialTitle":"A Multicentre, Multinational, Randomised, Parallel-group, Placebo-controlled (Double Blind) and Active-controlled (Open) Trial to Compare the Efficacy and Safety of Once Weekly Dosing of NNC0195-0092 (Somapacitan) With Once Weekly Dosing of Placebo and Daily Norditropin® FlexPro® in Adults With Growth Hormone Deficiency for 35 Weeks, Followed by a 53-week Open-label Extension Period","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-31","primaryCompletion":"2017-04-21","completion":"2018-05-07","firstPosted":"2014-09-03","resultsPosted":"2020-07-07","lastUpdate":"2020-11-23"},"enrollment":301,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Growth Hormone Disorder","Adult Growth Hormone Deficiency"],"interventions":[{"type":"DRUG","name":"somapacitan","otherNames":["NNC0195-0092"]},{"type":"DRUG","name":"somatropin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"NNC0195-0092 (somapacitan)","type":"EXPERIMENTAL"},{"label":"Daily hGH","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is conducted globally. The purpose is to demonstrate the efficacy of once weekly dosing of NNC0195-0092 (somapacitan) compared to placebo and once-daily dosing of somatropin (human growth hormone, hGH) after 35 weeks of treatment in adults with growth hormone deficiency.","primaryOutcome":{"measure":"Change in Truncal Fat Percentage (Week 34)","timeFrame":"Week -3, week 34","effectByArm":[{"arm":"Placebo","deltaMin":0.49,"sd":3.31},{"arm":"Norditropin","deltaMin":-2.39,"sd":4.48},{"arm":"Somapacitan","deltaMin":-1.17,"sd":2.89}],"pValues":[{"comp":"OG000 vs OG002","p":"=0.0090"}]},"eligibility":{"minAge":"23 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":117,"countries":["United States","Australia","Brazil","Germany","India","Israel","Japan","Latvia","Lithuania","Malaysia","Norway","Poland","Romania","Russia","South Africa","Sweden","Turkey (Türkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["32022863","39991735","36380045"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":61},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Diarrhoea","Arthralgia"]}}